Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Latest News

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

News All Time

Sleep Apnoea Tied to Heart Rhythm Risk in Dialysis Patients

Patients undergoing peritoneal dialysis who have sleep apnoea — particularly those older than 60 years — face an increased risk for new-onset atrial fibrillation, a Finnish study finds.

Overheard in Medicine: Who Owns the Incidental Finding?

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

How to Find the Sweet Spot for Cardio and Strength Training

Many people lean harder on one or the other — or do neither — but more science shows concurrent training may be the key to improved long-term health and vitality.

‘A Lot to Say’: Doctors Use Comics to Deliver Best Medicine

From comics-style stories to New Yorker cartoons, drawing is more than a creative outlet for these doctors — they’ve helped create an impactful new field: graphic medicine.

Preclinical Vascular Impairment Tied to Mortality

New criteria identifies preclinical vascular cognitive impairment in adults without dementia or stroke and linked it to higher cardiovascular risk and mortality.

Professional Corner: AMA Awards $1 Million in Grants

The AHA opens its health tech competition, AMA awards $1 million in community grants, and pediatricians call for stronger protections for children at the US border.

Gray-Market Retatrutide: Less Weight Loss, More CV Effects

Gray-market retatrutide use is increasing, but unapproved products aren’t delivering expected results. Its manufacturer Eli Lilly is calling for increased oversight.

Vutrisiran May Stabilize Right Ventricle Function in ATTR-CM

Right ventricular dysfunction is linked to worse outcomes in patients with transthyretin amyloidosis with cardiomyopathy; vutrisiran treatment may help stabilize right ventricular function.

Inhaling Cannabis Tied to Less Cardiac Ectopy in Adults

Adults without a history of cardiac arrhythmias have less cardiac ectopy on days they were randomly assigned to inhale cannabis than on days they abstained.

Mildly Elevated Ketones May Protect Kidneys in T2D

In patients with type 2 diabetes, mildly elevated blood ketone body levels are associated with a lower risk of developing kidney complications, a study finds.

Common ASM Tied to Twofold Thromboembolic Risk With DOACs

Levetiracetam has been linked to an increased thromboembolic risk among adults with epilepsy receiving DOACs, but experts caution that, at this point, the finding is not practice-changing.

An Accordion’s Unlikely Assist in Heart Research

Researchers applied the physics of the instrument to a new device that reproduces the heart’s complex blood flow waveforms.

Doctors Need Friends Outside Medicine, and It’s Not Easy

Doctors may find their closest friends in medicine and have little time for others. But experts say friendships outside the medical bubble matter more than ever.

Mushrooms Gain Ground in Medicine Despite Limited Evidence

Mushroom compounds show potential across cancer, metabolic, and neurologic research, but most evidence remains preclinical and larger clinical trials are still needed.

Medicine on Screen: 10 Films Doctors May Want to Rewatch

From Alzheimer’s to pandemics, these films show how medicine is lived as much as it is practiced.

Sequential or Simultaneous Therapy in Chronic Kidney Disease

Experts debate the pros and cons of stepwise vs simultaneous therapy for chronic kidney disease in an era of multifactorial treatment choices.

Recommended News For You

A new theranostic drug targets different cancer types.

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

The Benefits of Exercise for Substance Use Disorders.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Slowdown in progress found with cancer survival in England and Wales

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

Recommended Articles For You

Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery 

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine 

The Power of Romiplostim in Treating Low Platelet Counts  

Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

2.

Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection

3.

Implant-based reconstruction linked to increased risk of breast lymphomas

4.

Adult overdose deaths on the rise

5.

Simpler Screening Criteria Could Catch More Lung Cancers

1.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

2.

Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options 

3.

Patient Management for Bone Marrow Functional Recovery Pathways

4.

Engineered Red Blood Cell Therapeutics: Emerging Applications

5.

The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot